Lot-to-lot consistency study of the fully liquid pentavalent DTwP-HepB-Hib vaccine Quinvaxem® demonstrating clinical equivalence, suitability of the vaccine as a booster and concomitant administration with measles vaccine

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 8, 2012, Pages 1109-1118

  Aspinall, Sanet ^a   Traynor, Deirdre ^a   Bedford, Philip ^b   Hartmann, Katharina ^b  

^a Synexus Clinical Research SA (Pty) Ltd   (South Africa)

^b CRUCELL HOLLAND BV   (Netherlands)

Author keywords

Booster; Concomitant measles; Lot consistency; Pentavalent; Quinvaxem; Vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; MEASLES VACCINE;

ANTIBODY TITER; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CRYING; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; EATING HABIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INCIDENCE; INFANT; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; INJECTION SITE PAIN; INJECTION SITE RASH; INJECTION SITE REACTION; IRRITABILITY; MALE; MEASLES VACCINATION; MULTICENTER STUDY; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SIDE EFFECT; SOMNOLENCE; VOMITING;

ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DOUBLE-BLIND METHOD; DRUG TOXICITY; FEMALE; HAEMOPHILUS VACCINES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION; INFANT; MALE; MEASLES VACCINE; TECHNOLOGY, PHARMACEUTICAL;

EID: 84866102793     PISSN: None     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.21095     Document Type: Article

References (30)

1. World Health Organization (WHO). Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec 2010; 85:385-400; PMID:20939150.
2. Forsyth KD, Wirsing von Konig CH, Tan T, Caro J, Plotkin S. Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine 2007; 25:2634-42; PMID:17280745; http://dx.doi.org/10.1016/j.vaccine.2006.12.017.
3. Edwards KM, Decker MD. Pertussis vaccines. In: Plotkin SA, Orenstein WA, Offit P, eds. Vaccines. 7th ed. Philadelphia, PA: WB Saunders Company; 2008:467-517.
4. Vryheid RE, Kane MA, Muller N, Schatz GC, Bezabeh S. Infant and adolescent hepatitis B immunization up to 1999: a global overview. Vaccine 2000; 19:1026-37; PMID:11137236; http://dx.doi.org/10.1016/S0264-410X(00)00239-5.
5. World Health Organization (WHO). Hepatitis B vaccines. Wkly Epidemiol Rec 2009; 84:405-19; PMID:19817017.
6. World Health Organization (WHO). Expanded programme on immunization. global advisory group: Part I. Wkly Epidemiol Rec 1992; 67:11-5; PMID:1736955.
7. World Health Organization. WHO position paper on Haemophilus influenzae type b conjugate vaccines. (Replaces WHO position paper on Hib vaccines previously published in the Weekly Epidemiological Record. Wkly Epidemiol Rec 2006; 81:445-52; PMID:17124755.
8. World Health Organization (WHO). Introducing haemophilus influenzae type b conjugate vaccine into national immunization services. WHO fact sheet 2001.
9. Chandran A, Watt J, Santosham M. Haemophilus influenzae vaccines. In: Plotkin SA, Orenstein WA, Offit P, eds. Vaccines. 7th ed. Philadelphia, PA: WB Saunders Company; 2008:157-176.
10. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000; 13:302-17; PMID:10756001; http://dx.doi.org/10.1128/ CMR.13.2.302-317.2000.
11. World Health Organization (WHO). The children's vaccine initiative and the global programme for vaccines and immunization. recommendations from the special advisory group of experts. part I. Wkly Epidemiol Rec 1996; 71:261-6; PMID:8826779.
12. Decker M, Edwards K, Bogaerts H. Combination vaccines. In: Plotkin SA, Orenstein WA, Offit P, eds. Vaccines. 7th ed. Philadelphia, PA: WB Saunders Company; 2008:1069-1101.
13. European Medicines Agency (EMA). Scientific discussion; quintanrix.
14. Riedemann S, Reinhardt G, Jara J, Rios R, Wenzel MS, Willems P, et al. Immunogenicity and reactogenicity of combined versus separately administered DTPw-HBV and Hib vaccines given to healthy infants at 2, 4 and 6 months of age, with a booster at 18 months. Int J Infect Dis 2002; 6:215-22; PMID:12718838; http://dx.doi.org/10.1016/S1201-9712(02)90114-1.
15. Gatchalian S, Reyes M, Bernal N, Lefevre I, David MP, Han HH, et al. A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth. Hum Vaccin 2005; 1:198-203; PMID:17012860; http://dx.doi.org/10.4161/hv.1.5.2163.
16. Wiedenmayer KA, Weiss S, Chattopadhyay C, Mukherjee A, Kundu R, Ayé R, et al. Simplifying paediatric immunization with a fully liquid DTP-HepBHib combination vaccine: evidence from a comparative time-motion study in India. Vaccine 2009; 27:655-9; PMID:19056443; http://dx.doi.org/10.1016/j. vaccine.2008.11.045.
17. Drain PK, Nelson CM, Lloyd JS. Single-dose versus multi-dose vaccine vials for immunization programmes in developing countries. Bull World Health Organ 2003; 81:726-31; PMID:14758432.
18. Kanra G, Kara A, Demiralp O, Contorni M, Hilbert AK, Spyr C, et al. Safety and immunogenicity of a new fully liquid DTPw-HepB-Hib combination vaccine in infants. Hum Vaccin 2006; 2:155-60; PMID:17012890; http://dx.doi.org/10.4161/hv.2.4.2942.
19. Gentile A, Umido V, Czerniuk P, Nacul J, Seigelchifer M, Hilbert AK, et al. Immunogenicity and reactogenicity of a combined fully liquid DTPw-HepB-Hib pentavalent vaccine in healthy infants: no clinically relevant impact of a birth dose of hepatitis B vaccine. Int J Infect Dis 2011; 15:e24-9; PMID:21093342; http://dx.doi.org/10.1016/j.ijid.2010.09.004.
20. Suárez E, Asturias EJ, Hilbert AK, Herzog C, Aeberhard U, Spyr C. A fully liquid DTPw-HepB-Hib combination vaccine for booster vaccination of toddlers in El Salvador. Rev Panam Salud Publica 2010; 27:117-24; PMID:20339615; http://dx.doi.org/10.1590/S1020-49892010000200005.
21. Trotter CL, McVernon J, Andrews NJ, Burrage M, Ramsay ME. Antibody to Haemophilus influenzae type b after routine and catch-up vaccination. Lancet 2003; 361:1523-4; PMID:12737867; http://dx.doi.org/10.1016/S0140-6736(03)13172- 8.
22. Nascimento-Carvalho CM, de Andrade AL. Haemophilus influenzae type b vaccination: long-term protection. J Pediatr (Rio J) 2006; 82(Suppl):S109-14; PMID:16826309; http://dx.doi.org/10.2223/JPED.1501.
23. Deinhardt F, Zuckerman AJ. Immunization against hepatitis B: report on a WHO meeting on viral hepatitis in Europe. J Med Virol 1985; 17:209-17; PMID:4067587; http://dx.doi.org/10.1002/jmv.1890170302.
24. von Hunolstein C, Aggerbeck H, Andrews N, Berbers G, Fievet-Groyne F, Maple PA, et al. European seroepidemiology network: standardisation of the results of diphtheria antitoxin assays. Vaccine 2000; 18:3287-96; PMID:10869774; http://dx.doi.org/10.1016/S0264-410X(00)00125-0.
25. World Health Organization (WHO). The immunological basis for immunization series. module 3: Tetanus (galazka, AM).
26. Mertsola J, Ruuskanen O, Kuronen T, Meurman O, Viljanen MK. Serologic diagnosis of pertussis: evaluation of pertussis toxin and other antigens in enzyme-linked immunosorbent assay. J Infect Dis 1990; 161:966-71; PMID:2324547; http://dx.doi.org/10.1093/infdis/161.5.966.
27. Mariani M, Luzzi E, Proietti D, Mancianti S, Casini D, Costantino P, et al. A competitive enzyme-linked immunosorbent assay for measuring the levels of serum antibody to Haemophilus influenzae type b. Clin Diagn Lab Immunol 1998; 5:667-74; PMID:9729534.
28. Novartis Vaccines. Quattvaxem, product insert
29. Hla K, Thein S, Aye A, Han H, Bock H, David M, et al. Immuno- and reactogenicty profiles of a novel pentavalent DTPw-HepB/Hib vaccine: A randomised hib dose-ranging trial. 2005.
30. Tregnaghi M, López P, Rocha C, Rivera L, David MP, Rüttimann R, et al. A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America. Rev Panam Salud Publica 2006; 19:179-88; PMID:16640847; http://dx.doi.org/10.1590/S1020-49892006000300006.